Takeda Pharmaceutical Company Limited (NYSE: TAK), Fayetteville, AR – FDA Inspections
Inspection records and compliance data for Takeda Pharmaceutical Company Limited in Fayetteville, AR. 4 FDA inspections on record, last inspected June 27, 2019. Publicly traded as NYSE: TAK.
This profile covers Takeda Pharmaceutical Company Limited based in Fayetteville, AR, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected November 3, 2011. Last inspected June 27, 2019.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 27, 2019 | NAI | Biologics · Blood and Blood Products | 1097496 |
| June 16, 2016 | NAI | Biologics · Blood and Blood Products | 976688 |
| September 18, 2014 | NAI | Biologics · Blood and Blood Products | 896536 |
| November 3, 2011 | NAI | Biologics · Blood and Blood Products | 752377 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Takeda Pharmaceutical Company Limited
Stock ticker
TAK
Exchange
NYSE
Share price
$21.13
Market cap
$66.8B
Price as of
November 13, 2026
FEI Number
3000204650
Address
435 E Millsap Rd, Fayetteville, AR 72703-4066, United States
Country
United States
ID: b6d25059-c63d-40fa-a1d1-6ecb535f7e25